Amber Therapeutics: Landmark $100M Series A | LSI Europe '24

This keynote took place at LSI Europe ‘24 Emerging Medtech Summit in Sintra, Portugal.Led by Henry Peck, Aidan Crawley shares the story of Amber Therapeutics massive $100M Series A alongside several VCs who talk about the motivations behind the funding round.This keynote featured:Henry Peck — LSIAidan Crawley — Amber TherapeuticsMurielle Thinard McLane — Intuitive VenturesLiliane Chamas — Oxford Science EnterprisesCaroline Gaynor — Lightstone VenturesJoin us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summitsFollow us on social:LinkedIn: https://www.linkedin.com/company/life-science-intelligence/Twitter: https://twitter.com/lsintelligenceInstagram: https://www.instagram.com/lifescienceintelligence/Facebook: https://www.facebook.com/LifeScienceIntelligence/Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw

There are no comments yet.

Please log in to write the first comment.